Biogen, AbbVie withdraw multiple sclerosis drug Zinbryta
Biogen Inc and AbbVie Inc have withdrawn their multiple sclerosis drug worldwide due to safety issues, the companies said on Friday. FILE PHOTO: A sign marks a Biogen facility in Cambridge, Massachusetts, U.S. January 26, 2017.
from Biotech News
0 Comments